NORTHWESTERN MEDICINE EXPERTS AT THE
AHA SCIENTIFIC SESSIONS 2025
The American Heart Association (AHA) Scientific Sessions 2025 will be held from November 7 through 10 at Ernest N. Morial Convention Center in New Orleans, Louisiana. At AHA 2025, cardiologists, cardiac surgeons and experts in cardiovascular disease and stroke will have the opportunity to engage with other experts and expand their knowledge. This event serves as a platform for presenting and discussing the leading-edge research, advances in cardiovascular science and clinical breakthroughs.
NORTHWESTERN MEDICINE PRESENTATION HIGHLIGHTS
Friday, November 7
|
Time
|
Location
|
Session
|
Presenter
|
|
8:00 – 9:15 am CST
|
Room 208-209
|
An Introduction to Clinical Cardiovascular Genetic Testing Best Practices: A Flipped Classroom-Style Session
|
|
8:55 – 9:15 am CST
|
Room 238-239
|
Panel: AI Enabled QM&QI: Opportunities and Obstacles
|
|
11:00 am – 12:15 am CST
|
Room 238-239
|
QCOR Early Career Investigator Abstract Award Competition
|
|
12:38 – 12:46 pm CST
|
New Orleans Theater A
|
Examining the Guidelines for Low-Flow Low-Gradient Aortic Stenosis: Case Examples
|
|
1:00 – 1:50 pm CST
|
Room 225-227
|
Introduction and Application of the PREVENT Risk Calculator
|
|
1:14 – 1:22 pm CST
|
Room 260-262
|
Personal path from early career to leader in the field - Clinical Science
|
|
1:18 – 1:30 pm CST
|
Room 208-209
|
Cellular crosstalk: what cells to add to cardiomyopathy models?
|
|
2:45 – 2:55 pm CST
|
Room 220-222
|
Can we go back to ignoring disparities in care and outcomes?
|
|
3:10 – 3:25 pm CST
|
Room 225-227
|
Discuss Case Study 1 in Breakout Groups
|
|
4:00 – 5:15 pm CST
|
Room 208-209
|
Genomic and Precision Medicine Symposium: Model Systems: Preclinical to Phase I Bridge: Session 3, The Evolving Landscape of Regulation
|
Saturday, November 8
|
9:45 – 11:00 am CST
|
Room 215-216
|
Getting to the Grant
|
|
Forgotten No More: The Current Belle of the Ball? Breakthrough Evolutions in Hypertrophic Cardiomyopathy
|
|
9:45 – 11:00 am CST
|
Learning Studio 4
|
Controversies in Lifetime Management of Aortic Stenosis Patients Under 65 Years: TAVR vs SAVR First Strategy
|
|
10:11 – 10:16 am CST
|
Basic Science Zone‚ Moderated Digital Poster 25
|
Gαq-dependent signaling promotes atrial fibrillation through arrhythmogenic triggered calcium waves and inhomogeneous conduction in a canine heart failure model
|
|
10:30 – 11:30 am CST
|
Clinical Science Zone 2
|
The Aortic Valve in Context: Multimorbidity, Aging, and Systemic Impact
|
|
10:30 – 11:30 am CST
|
Basic Science Zone
|
Genomic Insights into Cardiac Valve and Aortic Disease
|
|
10:45 – 11:45 am CST
|
Basic Science Zone‚ Moderated Digital Poster 26
|
Cutting-Edge Gene and Precision Therapies
|
|
1:30 – 2:45 pm CST
|
Learning Studio 5
|
Hottest Clinical Trials in Valvular Heart Disease: Key Insights from Late-Breaking Studies
|
|
1:30 – 2:45 pm CST
|
Membership Lounge
|
Mastering Research and Writing in Cardiology: The Physician-Scientist’s Guide to Success
|
|
1:30 – 2:45 pm CST
|
Room 211-213
|
From Madrid to Mardi Gras: Heart Failure Trials on Parade
|
|
1:30 – 2:45 pm CST
|
Room 203-205
|
Genomic and Precision Medicine Early Career Investigator Award Competition
|
|
1:30 – 1:40 pm CST
|
New Orleans Theater B
|
Chronic Aortic Regurgitation: Is it Time to Revamp the Guidelines?
|
|
1:30 – 2:45 pm CST
|
New Orleans Theater B
|
TCT at AHA: Aortic Regurgitation: The New Frontier--Imaging, Interventions, and the Future of Treatment
|
|
2:17 – 2:31 pm CST
|
Room 231-232
|
The Hidden Risk Factor: Mental Health & Disparities in CVD Recovery
|
|
2:18 – 2:26 pm CST
|
Learning Studio 5
|
Mitral Transcatheter Edge-to-Edge Repair for Moderate Secondary Mitral Regurgitation Among Heart Failure Patients: Results from the EXPANDed Studies
|
|
3:15 – 4:30 pm CST
|
Room 217-219
|
HFpEF and CKM Syndrome: Overlap, Interplay and Opportunities to Optimize Outcomes
|
|
3:15 – 3:30 pm CST
|
Room 235-236
|
Digital Connections: Expanding Cardiovascular Care Through Innovation
|
|
3:15 – 4:30 pm CST
|
Main Event 2
|
The 2025 Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults
|
|
3:36 – 3:41 pm CST
|
Population Science Zone‚ Moderated Digital Poster 10
|
Cultural Identity and Cardiovascular Risk Factors in South Asian Young Adults in the United States: The MASALA-2G Second Generation Study
|
Sunday, November 9
|
8:00 – 9:15 am CST
|
Room 211-213
|
Biological and Pragmatic Interventions in Heart Failure: From Present to Future
|
|
8:00 – 8:07 am CST
|
Room 260-262
|
Risk Prediction (PREVENT Equations)
|
|
8:00 – 9:15 am CST
|
Room 224
|
Decoding MAC: High Risk Imaging Features and Their Impact on Outcomes for transcatheter therapies
|
|
8:25 – 8:30 am CST
|
Main Event 1
|
Discussant: DARE-AF
|
|
9:15 – 9:20 am CST
|
Population Science Zone‚ Moderated Digital Poster 13
|
Creation of U.S. Population-Based, Age- and Sex-Specific Percentile Reference Standards for Atherogenic Lipid Measurements
|
|
11:50 am – 1:05 pm CST
|
Clinical Science Zone 2‚ Moderated Digital Poster 19
|
Immunotherapy and Targeted Therapies in Cardio-Oncology
|
|
11:50 – 12:55 pm CST
|
Population Science Zone‚ Moderated Digital Poster 10
|
Multidimensional Risk Factors in Health: Social, Environmental, Behavioral, and Clinical Drivers of Disease
|
|
3:15 – 4:15 pm CST
|
Basic Science Zone
|
Plasminogen Activator Inhibitor-1 Governs Arterial Aging
|
|
3:30 – 4:30 pm CST
|
Membership Lounge
|
Making the Most of Mentoring
|
|
3:30 – 3:40 pm CST
|
New Orleans Theater A
|
Utilizing risk estimation in clinical practice
|
|
3:36 – 3:41 pm CST
|
Population Science Zone‚ Moderated Digital Poster 14
|
Parental Education and Cardiovascular Risk Factors in South Asian Young Adults in the United States: The MASALA-2G Second Generation Study
|
Monday, November 10
|
8:00 – 8:08 am CST
|
Room 224
|
How Young is Too Young for TAVR?: TAVR Should be Kept to Older Patients
|
|
8:00 – 8:12 am CST
|
Rivergate
|
Gene Therapies for Cardiac and Muscular Diseases
|
|
8:00 – 8:12 am CST
|
Room 224
|
TEER for Moderate MR: Treat it!
|
|
9:15 – 10:25 am CST
|
Clinical Science Zone 2‚ Moderated Digital Poster 20
|
Uncommon Pathways, Critical Lessons: Rare Complications and Remarkable Management in Structural and Valvular Heart Disease Case Presentations
|
|
9:45 – 11:00 am CST
|
Learning Studio 5
|
TCT at AHA: Heart Team in Action: Secondary MR: Still a Management Conundrum
|
|
10:15 – 10:25 am CST
|
Room 225-227
|
The promise, and pitfalls, of gene therapy trials in pediatric cardiology
|
|
12:50 – 12:55 pm CST
|
Clinical Science Zone 2‚ Moderated Digital Poster 17
|
Adverse Pregnancy Outcomes and Offspring Cardiovascular Health in Early Adulthood
|
|
1:30 – 2:45 pm CST
|
Room 271-273
|
The CAR-T Cardiac Storm: Cardiovascular Complications of CAR-T therapies
|
|
1:30 – 2:45 pm CST
|
Main Event 2
|
HFpEF in 2025: Trials and Triumphs
|
|
1:30 – 2:45 pm CST
|
Room 210
|
Heart Failure Wars: Gene Therapy Strikes Back: An AHA Journals Session
|
|
1:30 – 1:40 pm CST
|
Rivergate
|
Emerging AI-Support Tools for Maximizing Clinical Image Acquisition Efficiency
|
|
1:30 – 1:42 pm CST
|
Heart Theater 2
|
Risk scores to enable accessible precision care
|
|
1:42 – 1:54 pm CST
|
Room 224
|
Techquity for Cardiovascular Health
|
|
1:54 – 2:00 pm CST
|
Room 211-213
|
Commentary: Screening for Cardiac Amyloid
|
|
3:15 – 4:30 pm CST
|
Main Event 2
|
Cardiovascular Precision Therapy is at the Bedside
|
|
4:03 – 4:15 pm CST
|
Main Event 2
|
Navigating the Gene Therapy Frontier: Risks, Rewards, and Patient Safety
|
follow northwestern medicine Cardiovascular
|
|
|
|